文献速递腹部MR

肝细胞癌局部区域治疗后的MRI表现:一篇图谱综述

MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review.
PubMed 文献 · Abdom Radiol (NY) · 2022-05-07

本文以图谱综述形式介绍肝细胞癌经消融治疗、经动脉化疗栓塞、选择性内放射治疗和立体定向体部放疗后的MRI表现,并简述各治疗方法基本概念,强调放射科医生评估肿瘤反应对后续管理和移植资格判断的重要性。

要点

  • 消融、TACE、SIRT和SBRT后的MRI反应表现各异,需熟悉各自特征以准确评估肿瘤反应。
  • 放射科医生对治疗反应的评估可指导后续管理并可能影响移植资格。
  • 本文综述四种局部区域治疗后的影像反应并简述其基本概念。

核心结论

  • 放射科医生需理解不同局部区域治疗及其影像反应变化,以评估肝细胞癌治疗后肿瘤反应并指导后续管理。

研究设计与样本

  • 综述文章,以图谱综述形式描述消融治疗、经动脉化疗栓塞、选择性内放射治疗和立体定向体部放疗后的影像反应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide and within the United States. Liver transplant or partial liver resection is the definitive treatment of choice for HCC; however, the majority of cases are detected in advanced stages due to its early-stage asymptomatic nature, often precluding surgical treatment. Locoregional therapy plays an essential role in HCC management, including curative intent, as a bridge to transplant, or in some cases palliative therapy. Radiologists play a critical role in assessing tumor response following treatment to guide further management that may potentially impact transplantation eligibility; therefore, it is important for radiologists to have an understanding of different locoregional therapies and the variations of imaging response to different therapies. In this review article, we outline the imaging response to ablative therapy (AT), transarterial chemoembolization (TACE), selective internal radiation therapy (SIRT), and stereotactic body radiation therapy (SBRT). We will also briefly discuss the basic concepts of these locoregional therapies. This review focuses on the imaging features following locoregional treatment for hepatocellular carcinoma following AT, TACE, SIRT, and SBRT.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Alnammi, Wortman, Therrien, et al. MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review. Abdom Radiol (NY). 2022. PMID: 35524803. doi:10.1007/s00261-022-03526-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。